Chemical carcinogenesis models for evaluating molecular-targeted prevention and treatment of oral cancer

Cancer Prevention Research

Volumn 2, Issue 5, 2009, Pages 419-422

  Vitale Cross, Lynn ^a   Czerninski, Rakefet ^a   Amornphimoltham, Panomwat ^a   Patel, Vyomesh ^a   Molinolo, Alfredo A ^a   Gutkind, J Silvio ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 NITROQUINOLINE 1 OXIDE; 7,12 DIMETHYLBENZ[A]ANTHRACENE; DRINKING WATER; RAPAMYCIN;

CANCER PREVENTION; CANCER THERAPY; CHEMICAL CARCINOGENESIS; CHEMOPROPHYLAXIS; DISEASE COURSE; EXPERIMENTAL MODEL; GENE MUTATION; MOUTH CANCER; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; SQUAMOUS CELL CARCINOMA; TOOTH BRUSHING; ANIMAL; BIOLOGICAL MODEL; CELL TRANSFORMATION; GENETICS; HUMAN; MOUTH TUMOR; REVIEW;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; MODELS, BIOLOGICAL; MOUTH NEOPLASMS;

EID: 67650338317     PISSN: 19406207     EISSN: None     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-09-0058     Document Type: Short Survey

References (41)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
2. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin 2008;58:71-96.
3. Forastiere A, Koch W, Trotti A, Sidransky D. Head and neck cancer. N Engl J Med 2001;345:1890-1900
4. Mao L, Hong WK, Papadimitrakopoulou VA. Focus on head and neck cancer. Cancer Cell 2004;5:311-316
5. Molinolo AA, Amornphimoltham P, Squarize CH, Castilho RM, Patel V, Gutkind JS. Dysregulated molecular networks in head and neck carcinogenesis. Oral Oncol 2008. Sept. 18 [Epub ahead of print].
6. Lu SL, Herrington H, Wang XJ. Mouse models for human head and neck squamous cell carcinomas. Head Neck 2006;28:945-954 (Pubitemid 44497871)
7. Vitale-Cross L, Amornphimoltham P, Fisher G, Molinolo AA, Gutkind JS. Conditional expression of K-ras in an epithelial compartment that includes the stem cells is sufficient to promote squamous cell carcinogenesis. Cancer Res 2004;64:8804-8807 (Pubitemid 39665480)
8. Caulin C, Nguyen T, Longley MA, Zhou Z, Wang XJ, Roop DR. Inducible activation of oncogenic K-ras results in tumor formation in the oral cavity. Cancer Res 2004;64:5054-5058 (Pubitemid 39006517)
9. Kanojia D, Vaidya MM. 4-nitroquinoline-1-oxide induced experimental oral carcinogenesis. Oral Oncol 2006;42:655-667 (Pubitemid 44094232)
10. Czerninski R, Amornphimoltham P, Patel V, Molinolo AA, Gutkind JS. Targeting mammalian target of rapamycin by rapamycin prevents tumor progression in an oral-specific chemical carcinogenesis model. Cancer Prev Res (Phila Pa) 2009;2:27-36.
11. Dwivedi PP, Mallya S, Dongari-Bagtzoglou A. A novel immunocompetent murine model for Candida albicans-promoted oral epithelial dysplasia. Med Mycol 2008;1-11.
12. Fong LY, Jiang Y, Farber JL. Zinc deficiency potentiates induction and progression of lingual and esophageal tumors in p53-deficient mice. Carcinogenesis 2006;27:1489-1496 (Pubitemid 43985422)
13. Fujino H, Chino T, Imai T. Experimental production of labial and lingual carcinoma by local application of 4-nitroquinoline N-oxide. J Natl Cancer Inst 1965;35:907-918
14. Gannot G, Buchner A, Keisari Y. Interaction between the immune system and tongue squamous cell carcinoma induced by 4-nitroquinoline N-oxide in mice. Oral Oncol 2004;40:287-297 (Pubitemid 38121566)
15. Gunji A, Uemura A, Tsutsumi M, et al. Parp-1 deficiency does not increase the frequency of tumors in the oral cavity and esophagus of ICR/129Sv mice by 4-nitroquinoline 1-oxide, a carcinogen producing bulky adducts. Cancer Lett 2006;241:87-92.
16. Guttenplan JB, Kosinska W, von Pressentin MM, Rosa J, El-Bayoumy K. Effects of 1,4-phenylenebis (methylene)selenocyanate (p-XSC) and vitamin E on 4-nitroquinoline-N-oxide (4-NQO)-induced mutagenesis in lacZ mouse upper aerodigestive tissue. Mutat Res 2002;518:85-93. (Pubitemid 34626848)
17. Hasina R, Martin LE, Kasza K, Jones CL, Jalil A, Lingen MW. ABT-510 is an effective chemopreventive agent in the mouse 4-NQO model of oral carcinogenesis. Cancer Prev Res (Phila Pa) 2009;2:385-393
18. Hawkins BL, Heniford BW, Ackermann DM, Leonberger M, Martinez SA, Hendler FJ. 4NQO carcinogenesis: a mouse model of oral cavity squamous cell carcinoma. Head Neck 1994;16:424-432 (Pubitemid 24262590)
19. Ide F, Kitada M, Sakashita H, Kusama K, Tanaka K, Ishikawa T. p53 haploinsufficiency profoundly accelerates the onset of tongue tumors in mice lacking the xeroderma pigmentosum group A gene. Am J Pathol 2003;163:1729-1733 (Pubitemid 37310003)
20. Ide F, Oda H, Nakatsuru Y, et al. Xeroderma pigmentosum group A gene action as a protection factor against 4-nitroquinoline 1-oxide-induced tongue carcinogenesis. Carcinogenesis 2001;22:567-572 (Pubitemid 32288656)
21. Ishikawa T, Ide F, Qin X, et al. Importance of DNA repair in carcinogenesis: evidence from transgenic and gene targeting studies. Mutat Res 2001;477:41-49 (Pubitemid 32480187)
22. Kim TW, Chen Q, Shen X, et al. Oral mucosal carcinogenesis in SENCAR mice. Anticancer Res 2002;22:2733-2740 (Pubitemid 36069305)
23. Korpi JT, Kervinen V, Maklin H, et al. Collagenase-2 (matrix metalloproteinase-8) plays a protective role in tongue cancer. Br J Cancer 2008;98:766-775 (Pubitemid 351272624)
24. Ma G, Ikeda H, Inokuchi T, Sano K. Effect of photodynamic therapy using 5-aminolevulinic acid on 4-nitroquinoline-1-oxide-induced premalignant and malignant lesions of mouse tongue. Oral Oncol 1999;35:120-124 (Pubitemid 28546854)
25. Ma G, Sano K, Ikeda H, Inokuchi T. Promotional effects of CO(2) laser and scalpel incision on A-NQO-induced premalignant lesions of mouse tongue. Lasers Surg Med 1999;25:207-212
26. Miyamoto S, Yasui Y, Kim M, et al. A novel rasH2 mouse carcinogenesis model that is highly susceptible to 4-NQO-induced tongue and esophageal carcinogenesis is useful for preclinical chemoprevention studies. Carcinogenesis 2008;29:418-426 (Pubitemid 351359683)
27. Schoop RA, Baatenburg de Jong RJ, Noteborn MH. Apoptin induces apoptosis in an oral cancer mouse model. Cancer Biol Ther 2008;7:1368-1373
28. Steidler NE, Reade PC. Experimental induction of oral squamous cell carcinomas in mice with 4-nitroquinolone-1-oxide. Oral Surg Oral Med Oral Pathol 1984;57:524-531
29. Steidler NE, Reade PC. Initiation and promotion of experimental oral mucosal carcinogenesis in mice. J Oral Pathol 1986;15:43-47
30. Strati K, Pitot HC, Lambert PF. Identification of biomarkers that distinguish human papillomavirus (HPV)-positive versus HPV-negative head and neck cancers in a mouse model. Proc Natl Acad Sci U S A 2006;103:14152-14157 (Pubitemid 44452995)
31. Tang XH, Knudsen B, Bemis D, Tickoo S, Gudas LJ. Oral cavity and esophageal carcinogenesis modeled in carcinogen-treated mice. Clin Cancer Res 2004;10:301-313 (Pubitemid 38114193)
32. von Pressentin MM, El-Bayoumy K, Guttenplan JB. Mutagenic activity of 4-nitroquinoline-N-oxide in upper aerodigestive tissue in lacZ mice (Muta-Mouse) and the effects of 1, 4-phenylenebis(methylene)selenocyanate. Mutat Res 2000;466:71-78 (Pubitemid 30177141)
33. von Pressentin MM, Kosinska W, Guttenplan JB. Mutagenesis induced by oral carcinogens in lacZ mouse (MutaMouse) tongue and other oral tissues. Carcinogenesis 1999;20:2167-2170 (Pubitemid 29535320)
34. Young MR. Use of carcinogen-induced premalignant oral lesions in a dendritic cell-based vaccine to stimulate immune reactivity against both premalignant oral lesions and oral cancer. J Immunother 2008;31:148-156
35. Yuan B, Heniford BW, Ackermann DM, Hawkins BL, Hendler FJ. Harvey ras (H-ras) point mutations are induced by 4-nitroquinoline-1-oxide in murine oral squamous epithelia, while squamous cell carcinomas and loss of heterozygosity occur without additional exposure. Cancer Res 1994;54:5310-5317 (Pubitemid 24978129)
36. Yuan B, Oechsli MN, Hendler FJ. A region within murine chromosome 7F4, syntenic to the human 11q13 amplicon, is frequently amplified in 4NQO-induced oral cavity tumors. Oncogene 1997;15:1161-1170 (Pubitemid 27429619)
37. Zhang Z, Wang Y, Yao R, Li J, Lubet RA, You M. p53 Transgenic mice are highly susceptible to 4-nitroquinoline-1-oxide-induced oral cancer. Mol Cancer Res 2006;4:401-410 (Pubitemid 44035159)
38. Ikenaga M, Ishii Y, Tada M, Kakunaga T, Takebe H. Excision-repair of 4-nitroquinolin-1-oxide damage responsible for killing, mutation, and cancer. Basic Life Sci 1975;5B:763-771
39. Kim MM, Glazer CA, Mambo E, et al. Head and neck cancer cell lines exhibit differential mitochondrial repair deficiency in response to 4NQO. Oral Oncol 2006;42:201-207 (Pubitemid 43106885)
40. Seong E, Saunders TL, Stewart CL, Burmeister M. To knockout in 129 or in C57BL/6: that is the question. Trends Genet 2004;20:59-62. (Pubitemid 38121354)
41. Wong KK. Oral-specific chemical carcinogenesis in mice: an exciting model for cancer prevention and therapy. Cancer Prev Res (Phila Pa) 2009;2:10-13